"The need for vascular access improvement is an international one," explained Holland. "DaVita has had an incredible amount of success in its vascular access initiatives, but we are always striving to improve our methods. This opportunity to share and learn from the vascular access management of other countries is essential to continuing the highest quality treatment of our patients."
Holland's presentation discussed the 2006 vascular access guidelines and the importance of checking for access maturation before the first cannulation. Key points addressed were to assess the patient and watch for redness, edema, bruising, asymmetry or drainage, changes in skin color, temperature or signs of numbness. Comparing these symptoms to their opposite extremity is also important in determining abnormalities.
DaVita CEO Kent Thiry stated, "Janet has been a thoughtful, dedicated
citizen of the kidney care community for years. We are very proud to see
her receive this level of recognition for her work."
(1) Fistula First National Vascular Access Improvement Initiative Website
(http://www.fistulafirst.org), adjusted to exclude DVA from the
national average; DaVita data is the average of reported DaVita and
Gambro Healthcare data.
(2) Per the 2006 USRDS Annual Report as reported for 2004.
About DaVita Inc.
DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney
care in the United States, providing dialysis services and education for
patients with chronic kidney failure and end stage renal disease. DaVita
'/>"/>
| SOURCE DaVita Inc. Copyright©2007 PR Newswire. All rights reserved |